Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

• Post author:GHIAA Admin
• Post published:September 10, 2021
• Post category:

Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement

CEPI – Valneva, Chikungunya Vaccine Funding Agreement

• Post author:GHIAA Admin
• Post published:August 25, 2021
• Post category:

Continue ReadingCEPI – Valneva, Chikungunya Vaccine Funding Agreement

Gilead – Indian Generic Manufacturers, HCV License Agreement

• Post author:GHIAA Admin
• Post published:August 18, 2021
• Post category:

Continue ReadingGilead – Indian Generic Manufacturers, HCV License Agreement

Fiocruz – AstraZeneca, COVID-19 Technological Order Agreement

• Post author:GHIAA Editor
• Post published:July 1, 2021
• Post category:

Continue ReadingFiocruz – AstraZeneca, COVID-19 Technological Order Agreement

Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

• Post author:GHIAA Admin
• Post published:December 14, 2020
• Post category:

Continue ReadingSanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement

Merck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingMerck – Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement

MPP – BMS – Aurobindo, Daclatasvir Sublicense & Tech Transfer Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingMPP – BMS – Aurobindo, Daclatasvir Sublicense & Tech Transfer Agreement

MPP – Gilead, TDF License Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingMPP – Gilead, TDF License Agreement

CEPI CfP3i Template Funding Agreement

• Post author:GHIAA Editor
• Post published:May 22, 2020
• Post category:

Continue ReadingCEPI CfP3i Template Funding Agreement